Young Joseph R
SEC CIK 1861684 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | SVP, Fin, Chief Acct Offcr | 80.8K | $80.0K | $2.10M | 15 | 2022-02-06 | 2026-09-11 |
Most active insiders at VERA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fordyce Marshall | Pres AND CEO, Dir | — | $9.73M |
| 2 | Turner William D. | Chief Regulatory Off | — | $1.45M |
| 3 | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | — | $566.8K |
| 4 | ENRIGHT PATRICK G | Dir | $250.0K | — |
| 5 | Grant Sean | CFO | — | $207.8K |
| 6 | JOHNSON DAVID LEE | COO | — | $108.3K |
| 7 | Carter Jason S | CLO | — | $107.5K |
| 8 | Brenner Robert | Chief Medical Off | — | $90.3K |
| 9 | Skelton Laurence Matthew | Chief Commercial Off | — | $66.4K |
| 10 | Boman Nancy Lee | Chief Regulatory Off | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-14 16:28 | 2026-09-11 | VERA | Vera Therapeutics, Inc. | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | M - OptEx | $3.94 | +5,000 | 80.8K | +7% | +$19.7K |
| D | 2026-03-16 | 2026-03-13 | VERA | Vera Therapeutics, Inc. | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | M - OptEx | $3.94 | +10.0K | 75.8K | +15% | +$39.4K |
| 2026-02-25 | 2026-02-23 | VERA | Vera Therapeutics, Inc. | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | S - Sale | $41.98 | -3,117 | 64.7K | -5% | -$130.9K | |
| D | 2026-02-06 | 2026-02-04 | VERA | Vera Therapeutics, Inc. | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | A - Grant | $0.00 | +10.0K | 67.8K | +17% | $0 |
| D | 2025-11-13 | 2025-11-13 | VERA | Vera Therapeutics, Inc. | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | M - OptEx | $3.94 | +10.0K | 57.8K | +21% | +$39.4K |
| D | 2025-11-13 | 2025-11-11 | VERA | Vera Therapeutics, Inc. | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | S - Sale+OE | $29.06 | -15.0K | 47.8K | -24% | -$435.9K |
| D | 2025-02-20 | 2025-02-18 | VERA | Vera Therapeutics, Inc. | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | A - Grant | $0.00 | +10.7K | 61.9K | +21% | $0 |
| DM | 2024-05-17 | 2024-05-15+ | VERA | Vera Therapeutics, Inc. | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | S - Sale+OE | $42.30 | -30.8K | 53.2K | -37% | -$1.30M |
| DM | 2024-05-17 | 2024-05-15+ | VERA | Vera Therapeutics, Inc. | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | M - OptEx | $6.75 | +28.9K | 61.4K | +89% | +$194.9K |
| 2024-04-12 | 2024-04-10 | VERA | Vera Therapeutics, Inc. | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | S - Sale | $40.00 | -5,714 | 53.2K | -10% | -$228.6K | |
| D | 2024-01-18 | 2024-01-16 | VERA | Vera Therapeutics, Inc. | Young Joseph R | SVP, Fin, CHIEF ACCT OFFCR | A - Grant | $0.00 | +21.9K | 57.1K | +62% | $0 |
| D | 2023-07-06 | 2023-07-05 | VERA | Vera Therapeutics, Inc. | Young Joseph R | SVP, Fin, Chief Acct Offcr | M - OptEx | $3.94 | +10.0K | 32.7K | +44% | +$39.4K |
| A | 2023-02-17 | 2023-02-06 | VERA | Vera Therapeutics, Inc. | Young Joseph R | SVP, Fin, Chief Acct Offcr | P - Purchase | $7.00 | +5,714 | 22.7K | +34% | +$40.0K |
| 2023-02-08 | 2022-02-06 | VERA | Vera Therapeutics, Inc. | Young Joseph R | SVP, Fin, Chief Acct Offcr | P - Purchase | $7.00 | +5,714 | 22.7K | +34% | +$40.0K | |
| 2022-08-23 | 2022-08-19 | VERA | Vera Therapeutics, Inc. | Young Joseph R | SVP, Fin, Chief Acct Offcr | A - Grant | $0.00 | +15.0K | 16.1K | +1,307% | $0 |
Purchase Sale Sale after option exercise All abbreviations